Last reviewed · How we verify

NCT06658691

Multidisciplinary Approach to Improve Diabetic Foot Care: an Investigation of Clinical and Economic Outcomes.

Completed NA Last updated 26 October 2024
What this trial tests

NA trial testing Multidisciplinary approach in Multidisciplinary Approach in 119 participants. Completed in 30 December 2022.

Timeline
17 July 2022
Primary endpoint
30 December 2022
30 December 2022

Quick facts

Lead sponsorUniversity of Jordan
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposehealth services research
Enrollment119
Start date17 July 2022
Primary completion30 December 2022
Estimated completion30 December 2022
Sites1 location across Jordan

Drugs / interventions tested

Conditions studied

Sponsor

University of Jordan

Who can join

18 and older, any sex, with Multidisciplinary Approach or Clinical Pharmacists. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study intervention was applying multidisciplinary approach consisting of an endocrinologist, a diabetes specialized nurse, and a clinical pharmacist to assess and improve diabetic foot care using a systematic screening, patients' risk categorization, therapy optimization, and tailored education.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Multidisciplinary approach

Trials testing the same drug.

Other recruiting trials for Multidisciplinary Approach

Currently open trials in the same condition.

Other University of Jordan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06658691.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing